/Investor DB

Cambridge Innovation Capital — 2019 Investments

4 investments dated 2019 · listed companies and verified rows first · show all

Imagenimagen.ioin𝕏Jan 2019✓ verifiedAcquired

Imagen builds a video management platform designed to help clients make video content measurable, manageable, and profitable.

AI & Machine LearningCloud ComputingData & InfrastructureEnterprise SoftwareMedia & EntertainmentSaaSLondon, GB

Anthony BlakePaul McConkey

Co-investorsGuinness Asset ManagementGuinness VenturesWormhole CapitalCadenzaHaystackMenlo Ventures+3 more

Gyroscopetxgyroscopetx.comin𝕏Series B · Sep 2019 · $61M

Novartis is a pharmaceutical company that develops and commercializes prescription medicines and therapies across therapeutic areas including oncology, cardiovascular disease, and immunology.

BiotechMedical Devices

Co-investorsSofinnova Ventures

Riverlaneriverlane.comJun 2019

Riverlane builds quantum error correction hardware and software, including its Deltaflow real-time QEC system, for quantum computer makers.

Cambridge, GB

Steve Brierley(Founder)in

Co-investorsAmadeus Capital PartnersETF PartnersMolten VenturesAltaIR CapitalUniversity of Cambridge Enterprise

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

PredictImmune

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.